248 related articles for article (PubMed ID: 16236891)
1. Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis.
Robinson TE; Goris ML; Zhu HJ; Chen X; Bhise P; Sheikh F; Moss RB
Chest; 2005 Oct; 128(4):2327-35. PubMed ID: 16236891
[TBL] [Abstract][Full Text] [Related]
2. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
[TBL] [Abstract][Full Text] [Related]
3. Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease.
Robinson TE; Leung AN; Northway WH; Blankenberg FG; Chan FP; Bloch DA; Holmes TH; Moss RB
Am J Respir Crit Care Med; 2003 Sep; 168(5):588-93. PubMed ID: 12746252
[TBL] [Abstract][Full Text] [Related]
4. Spirometer-triggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis.
Robinson TE; Leung AN; Northway WH; Blankenberg FG; Bloch DA; Oehlert JW; Al-Dabbagh H; Hubli S; Moss RB
J Pediatr; 2001 Apr; 138(4):553-9. PubMed ID: 11295720
[TBL] [Abstract][Full Text] [Related]
5. Quantitative air-trapping analysis in children with mild cystic fibrosis lung disease.
Bonnel AS; Song SM; Kesavarju K; Newaskar M; Paxton CJ; Bloch DA; Moss RB; Robinson TE
Pediatr Pulmonol; 2004 Nov; 38(5):396-405. PubMed ID: 15390349
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment.
Shah PI; Bush A; Canny GJ; Colin AA; Fuchs HJ; Geddes DM; Johnson CA; Light MC; Scott SF; Tullis DE
Eur Respir J; 1995 Jun; 8(6):954-8. PubMed ID: 7589382
[TBL] [Abstract][Full Text] [Related]
7. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
Laube BL; Auci RM; Shields DE; Christiansen DH; Lucas MK; Fuchs HJ; Rosenstein BJ
Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis.
Judge EP; Dodd JD; Masterson JB; Gallagher CG
Chest; 2006 Nov; 130(5):1424-32. PubMed ID: 17099020
[TBL] [Abstract][Full Text] [Related]
9. High resolution computerized tomography of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis patients.
Nasr SZ; Gordon D; Sakmar E; Yu X; Christodoulou E; Eckhardt BP; Strouse PJ
Pediatr Pulmonol; 2006 Dec; 41(12):1129-37. PubMed ID: 17068818
[TBL] [Abstract][Full Text] [Related]
10. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.
McCoy K; Hamilton S; Johnson C
Chest; 1996 Oct; 110(4):889-95. PubMed ID: 8874241
[TBL] [Abstract][Full Text] [Related]
11. [Effect of rhDNase on the respiratory function and nutritional status of children and adolescents with mucoviscidosis].
Wizla-Derambure N; Michaud L; Sardet A; Deschildre A; Loeuille GA; Tassin E; Loire N; Buisine C; Boutry E; Dias J; Hecquet F; Turck D
Arch Pediatr; 1998 Apr; 5(4):378-83. PubMed ID: 9759156
[TBL] [Abstract][Full Text] [Related]
12. Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study.
Nasr SZ; Kuhns LR; Brown RW; Hurwitz ME; Sanders GM; Strouse PJ
Pediatr Pulmonol; 2001 May; 31(5):377-82. PubMed ID: 11340684
[TBL] [Abstract][Full Text] [Related]
13. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
Hodson ME
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
[TBL] [Abstract][Full Text] [Related]
14. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.
Gustafsson PM; De Jong PA; Tiddens HA; Lindblad A
Thorax; 2008 Feb; 63(2):129-34. PubMed ID: 17675316
[TBL] [Abstract][Full Text] [Related]
15. The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease.
Nasr SZ; Sakmar E; Christodoulou E; Eckhardt BP; Streetman DS; Strouse PJ
Pediatr Pulmonol; 2010 May; 45(5):440-9. PubMed ID: 20425851
[TBL] [Abstract][Full Text] [Related]
16. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests.
Brody AS; Klein JS; Molina PL; Quan J; Bean JA; Wilmott RW
J Pediatr; 2004 Jul; 145(1):32-8. PubMed ID: 15238903
[TBL] [Abstract][Full Text] [Related]
17. Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.
Bakker EM; Volpi S; Salonini E; Müllinger B; Kroneberg P; Bakker M; Hop WC; Assael BM; Tiddens HA
Pediatr Pulmonol; 2014 Feb; 49(2):154-61. PubMed ID: 23913868
[TBL] [Abstract][Full Text] [Related]
18. Clinical studies of rhDNase in moderately and severely affected patients with cystic fibrosis--an overview.
Hodson ME
Respiration; 1995; 62 Suppl 1():29-32. PubMed ID: 7792438
[TBL] [Abstract][Full Text] [Related]
19. Air trapping on expiratory high-resolution CT scans in the absence of inspiratory scan abnormalities: correlation with pulmonary function tests and differential diagnosis.
Arakawa H; Webb WR
AJR Am J Roentgenol; 1998 May; 170(5):1349-53. PubMed ID: 9574614
[TBL] [Abstract][Full Text] [Related]
20. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
Suri R; Metcalfe C; Wallis C; Bush A
Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
